Growth Metrics

Quest Diagnostics (DGX) Cost of Revenue (2016 - 2026)

Quest Diagnostics' Cost of Revenue history spans 18 years, with the latest figure at $2.0 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 9.17% to $2.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.5 billion, a 10.44% increase, with the full-year FY2025 number at $7.4 billion, up 11.19% from a year prior.
  • Cost of Revenue hit $2.0 billion in Q1 2026 for Quest Diagnostics, up from $1.9 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for DGX hit a ceiling of $2.0 billion in Q1 2026 and a floor of $1.5 billion in Q3 2023.
  • Historically, Cost of Revenue has averaged $1.7 billion across 5 years, with a median of $1.6 billion in 2022.
  • Biggest five-year swings in Cost of Revenue: decreased 8.32% in 2022 and later grew 14.12% in 2025.
  • Tracing DGX's Cost of Revenue over 5 years: stood at $1.6 billion in 2022, then dropped by 1.46% to $1.6 billion in 2023, then grew by 13.6% to $1.8 billion in 2024, then grew by 7.54% to $1.9 billion in 2025, then grew by 3.01% to $2.0 billion in 2026.
  • Business Quant data shows Cost of Revenue for DGX at $2.0 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.9 billion in Q3 2025.